179. Williams syndrome Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 12 / Drugs : 21 - (DrugBank : 8) / Drug target genes : 9 - Drug target pathways : 35
Williams syndrome and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)
| ID | Diseases (Sorted by score) | Score |
|---|---|---|
| 179 | Williams syndrome | - |
| 6 | Parkinson disease | 7.149 |
| 21 | Mitochondrial disease | 5.676 |
| 13 | Multiple sclerosis/Neuromyelitis optica | 5.485 |
| 206 | Fragile X syndrome | 4.222 |
| 299 | Cystic fibrosis | 4.125 |
| 8 | Huntington disease | 2.910 |
| 97 | Ulcerative colitis | 2.855 |
| 120 | Hereditary dystonia | 2.000 |
| 17 | Multiple system atrophy | 1.923 |
| 156 | Rett syndrome | 1.893 |
| 46 | Malignant rheumatoid arthritis | 1.826 |
| 187 | Kabuki syndrome | 1.481 |
| 171 | Wilson disease | 1.481 |
| 127 | Frontotemporal lobar degeneration | 1.150 |
| 18 | Spinocerebellar degeneration | 1.133 |
| 140 | Dorabe syndrome | 1.125 |
| 113 | Muscular dystrophy | 1.102 |
| 86 | Pulmonary arterial hypertension | 1.060 |
| 96 | Crohn disease | 1.036 |
| 2 | Amyotrophic lateral sclerosis | 1.035 |